This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nanostring Technologies, Inc. for $65,992.00. The contract is for the delivery of reagents and consumables for Nanostring's existing CosMx Spatial Molecular Imager, a genomic analysis platform used to support biomedical research and healthcare programs across various government agencies. Nanostring Technologies is a publicly held provider of life science...
Nanostring Technologies, Inc. has been awarded a $24,641 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide CMX KITS from Nanostring Technologies Inc. The place of performance will be Nanostring's facilities located in Seattle, Washington. The firm fixed price order is for the period of September 18, 2023 through November 18, 2023. No additional details were provided regarding the original solicitation or use of the CMX KITS...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $15,000 purchase order to Nanostring Technologies, Inc. to provide consumable RNA assays for the COSMX/CMX platform. The assays will support research efforts taking place in Seattle, Washington through December 2023. As a firm fixed price contract, Nanostring will deliver the specified RNA assays for the agreed upon total value. The award utilizes an existing Governmentwide Acquisition Contract...
This is a federal contract award to Nanostring Technologies, Inc. for the provision of COSMX AND GEOMX CONSUMABLES. The contract has a ceiling value of $47,901.00 and was awarded by the National Institute on Aging, a civilian federal agency. The contract is a firm-fixed price Purchase Order that will run through August 22, 2024. There is no set-aside designation for this award. Nanostring Technologies is a publicly-held provider of life science tools and advanced genomic analysis platforms,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,794.60 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under the firm fixed price contract, Nanostring will provide GEOMX REAGENT KITS to support the agency's research efforts. The contract has a one year period of performance beginning September 2025 through September 2024. No set aside designation or subcontractors were indicated....
This $90,793 purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Nanostring Technologies, Inc., a provider of advanced genomic analysis platforms. The contract is for the procurement of consumable fluids for the GeoMx Digital Spatial Profiler, a novel technology that enables spatially-resolved, digital quantification of proteins and RNA in tissue samples. The award is not designated as a set-aside contract....
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Nanostring Technologies, Inc., a publicly held provider of life science tools for translational research and molecular diagnostics. The contract, valued at $17,832.50, is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs across...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $14,788 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under the contract, Nanostring will provide NANOSTRING REAGENT KITS (AMBIS #2186668) to support NIH/NIAID research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring's reagents will aid...
This $16,420 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools for translational research and molecular diagnostics. The contract is not set aside for any specific business type. Under this award, Nanostring will deliver specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $15,366.00 firm fixed-price purchase order contract to Nanostring Technologies, Inc. for the supply of NANOSTRING TECHNOLOGIES INC (AMBIS #2223210) CONSUMABLE XT TAG SETRNA BIOLOGICAL PRODUCTS. This is a non-set-aside contract with an ultimate completion date of August 1, 2024. Nanostring Technologies, Inc. is a publicly traded provider of life science tools and services, including advanced genomic analysis platforms...